As common—and costly—as off-label prescribing is in oncology, it is poorly understood. It is, by nature, hard to study. Yet it is clear that the practice is changing. Skyrocketing drug costs, ...
Reimbursement for Cancer Treatment: Coverage of Off-Label Drug Indications. If you have the appropriate software installed, you can download article citation data to the citation manager of your ...
The amount varies as most employers offer assistance reimbursement up to $5,250 per year since that amount equates to being tax-deductible. While employees struggle with their employers’ lack of ...
The European Court of Justice refused to stand in the way Wednesday of Italy’s reimbursement of the cancer drug Avastin for an off-label use: the treatment of age-related macular degeneration. (CN) - ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. In accordance with federal law, the Centers for Medicare and ...
The Food and Drug Law Journal is a peer-reviewed quarterly devoted to the scholarly analysis of legislation, regulations, court decisions, and public policies affecting the development, manufacture, ...
Medicaid is characterized by low rates of provider participation, often attributed to reimbursement rates below those of commercial insurance or Medicare. Understanding the extent to which Medicaid ...
DUBLIN--(BUSINESS WIRE)--The "Strategic Opportunities Within Private Label in Tissue and Hygiene" company profile has been added to ResearchAndMarkets.com's offering. This report explores growth ...
Abstract Approximately half of the uses of anticancer chemotherapy drugs are for indications other than those referenced in the United States Food and Drug Administration approved label. Some managed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback